Patent Assignment
Reel/Frame 046284/0674
Change of Name
Recorded: 2018-05-31
Pages: 3
Assignor
SCPHARMACEUTICALS LLC
Executed: 2014-03-24
Assignee
SCPHARMACEUTICALS INC.
131 HARTWELL AVENUE, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Pharmaceutical Formulations for Subcutaneous Administration of Furosemide
Related Assignments
(13)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 31, 2018
From: MUNTENDAM, PIETER
To: SCPHARMACEUTICALS INC.
Reel/Frame 045954/0151 →
Assignment of Assignor's Interest
May 31, 2018
From: LARSEN, GLENN R.; MICHAELS, SCOTT A.
To: SCPHARMACEUTICALS, LLC
Reel/Frame 045954/0096 →
Assignment of Assignor's Interest
Jul 25, 2018
From: LARSEN, GLENN R.; MICHAELS, SCOTT A.
To: SCPHARMACEUTICALS, LLC
Reel/Frame 046453/0706 →
Change of Name
Jul 25, 2018
From: SCPHARMACEUTICALS LLC
To: SCPHARMACEUTICALS INC.
Reel/Frame 046623/0415 →
Assignment of Assignor's Interest
Jul 25, 2018
From: MUNTENDAM, PIETER
To: SCPHARMACEUTICALS INC.
Reel/Frame 046453/0703 →
Intellectual Property Security Agreement
Sep 17, 2019
From: SCPHARMACEUTICALS INC.
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 050399/0462 →
Security Interest
Oct 13, 2022
From: SCPHARMACEUTICALS INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 061419/0196 →
Release of Security Interest
Oct 13, 2022
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: SCPHARMACEUTICALS INC.
Reel/Frame 061419/0151 →
Release of Security Interest
Aug 9, 2024
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: SCPHARMACEUTICALS INC.
Reel/Frame 068244/0093 →
Security Interest
Aug 13, 2024
From: SCPHARMACEUTICALS INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 068261/0702 →
Release of Security Interest
Oct 8, 2025
From: PERCEPTIVE CREDIT HOLDINGS IV, LP
To: SCPHARMACEUTICALS INC.
Reel/Frame 072511/0726 →
Patent Security Agreement
Nov 11, 2025
From: SCPHARMACEUTICALS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 073569/0001 →
Assignment of Assignor's Interest
Aug 5, 2026
From: SCPHARMACEUTICALS INC.
To: MANNKIND CORPORATION
Reel/Frame 075534/0523 →